(BPT) – Do you live with persistent, moderate-to-severe asthma, COPD, allergies, eczema or hives? Inflammation is often a major factor in the severity of your symptoms. It could also be a factor if ...
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, shares the latest clinical discoveries from the BOREAS trial on type 2 inflammation in patients with chronic ...
Reynold A. Panettieri Jr., MD, examines the application of biologic therapies in the treatment of respiratory conditions. Biologics are currently available for asthma management and being studied in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The phase 3 BOREAS trial included adults with ...
Verywell Health on MSN
Is Type 2 Diabetes an Autoimmune Disease?
Type 2 diabetes is not an autoimmune condition, while type 1 diabetes is. Though new research suggests the immune system may ...
Bhatt’s study, "Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts,” was recently published in The New England Journal of Medicine. Bhatt and colleagues conducted a multicenter ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients receiving mepolizumab vs. placebo had a smaller ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results